The Middle East and Africa pharmaceutical industry is entering a new era, with the development of infrastructure system and rapidly changing regulations. The industry is blessed with several advantages like high prevalence of diseases, huge population base and many more, reflecting bight prospects of growth in coming years. With these supportive factors, the pharmaceutical industry in the MEA region is expected to outperform the pharmaceutical industry of other regions in near future. According to our new analytical research study 'Middle East and Africa Pharma Sector Forecast to 2012', the pharmaceutical market in the region is expected to grow at a CAGR of around 11% during 2010-2012. Presently, the market is characterized by major changes in regulation policies of every country. Anticipating the future growth, many private key players are investing heavily in the industry to get a pie of the chunk.Our report has found that the countries like South Africa, Saudi Arabia and Israel are currently dominating the pharmaceutical industry of the whole region. These countries have better position than others in terms of infrastructure and regulatory environment. We have also found that MEA pharmaceutical industry is based on import, with most of the drugs and therapeutics are procured from overseas countries and generics hold a majority share. The governments of respective countries are trying to increase their domestic production by investing heavily in the industry. Overall, the growth of the industry is expected to bolster in near future. Our report also provides extensive information on the Middle East and Africa pharmaceutical market, with detailed description of country level market. It also highlights several emerging market trends like generics, healthcare insurance market, etc. The research study gives detailed statistical and analytical review of healthcare demographics, key drivers and restraints. It contains comprehensive information along with rational analysis that will help clients to draw up market strategies and assess opportunity areas in the Middle East and Africa pharmaceutical market.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Middle East and Africa Pharma Sector Forecast to 2012
Published on September 2009
Report Summary
The Middle East and Africa pharmaceutical industry is entering a new era, with the development of infrastructure system and rapidly
changing regulations. The industry is blessed with several advantages like high prevalence of diseases, huge population base and
many more, reflecting bight prospects of growth in coming years. With these supportive factors, the pharmaceutical industry in the
MEA region is expected to outperform the pharmaceutical industry of other regions in near future.
According to our new analytical research study 'Middle East and Africa Pharma Sector Forecast to 2012', the pharmaceutical market
in the region is expected to grow at a CAGR of around 11% during 2010-2012. Presently, the market is characterized by major
changes in regulation policies of every country. Anticipating the future growth, many private key players are investing heavily in the
industry to get a pie of the chunk.
Our report has found that the countries like South Africa, Saudi Arabia and Israel are currently dominating the pharmaceutical industry
of the whole region. These countries have better position than others in terms of infrastructure and regulatory environment. We have
also found that MEA pharmaceutical industry is based on import, with most of the drugs and therapeutics are procured from overseas
countries and generics hold a majority share. The governments of respective countries are trying to increase their domestic
production by investing heavily in the industry. Overall, the growth of the industry is expected to bolster in near future.
Our report also provides extensive information on the Middle East and Africa pharmaceutical market, with detailed description of
country level market. It also highlights several emerging market trends like generics, healthcare insurance market, etc. The research
study gives detailed statistical and analytical review of healthcare demographics, key drivers and restraints. It contains
comprehensive information along with rational analysis that will help clients to draw up market strategies and assess opportunity
areas in the Middle East and Africa pharmaceutical market.
Table of Content
1. Analyst View
2. Global Pharmaceutical Market Overview
2.1 Market Size and Growth
2.2 Leading Drugs
3. MEA Pharmaceutical Market Overview
4. By Country
4.1 Egypt
4.1.1 Market Overview
4.1.2 Future Outlook
4.1.3 Regulatory Environment
4.1.4 Key Players
4.2 Nigeria
4.2.1 Market Overview
4.2.2 Future Outlook
Middle East and Africa Pharma Sector Forecast to 2012 Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
4.2.3 Regulatory Environment
4.2.4 Key Players
4.3 South Africa
4.3.1 Market Overview
4.3.2 Future Outlook
4.3.3 Regulatory Environment
4.3.4 Key Players
4.4 Israel
4.4.1 Market Overview
4.4.2 Future Outlook
4.4.3 Regulatory Environment
4.4.4 Key Players
4.5 Saudi Arabia
4.5.1 Market Overview
4.5.2 Future Outlook
4.5.3 Regulatory Environment
4.5.4 Key Players
4.6 UAE
4.6.1 Market Overview
4.6.2 Future Outlook
4.6.3 Regulatory Environment
4.6.4 Key Players
4.7 Algeria
4.7.1 Market Overview
4.7.2 Future Outlook
4.7.3 Regulatory Environment
4.7.4 Key Players
5. Emerging Market Trends
5.1 Low Manufacturing Cost
5.2 Highly Untapped Market
5.3 Generics
5.4 High Prevalence of Diseases
5.5 Healthcare Insurance Market
6. Industry Restraints and RNCOS Recommendation
6.1 Weak IPR Protection
6.2 Weak Distribution Infrastructure
6.3 High Dependence on Import
6.4 High Cost of Drugs
List of Figures:
Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2004-2009
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2004-2008
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-1: Middle East & Africa - Pharmaceutical Market (Billion US$), 2007-2009
Figure 3-2: Middle East & Africa - Pharmaceutical Market by Country (%) 2008
Figure 3-3: Middle East & Africa - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 3-4: Middle East & Africa - Forecast for Pharmaceutical Market by Country (%), 2012
Figure 4-1: Egypt - Pharmaceutical Market (Billion US$), 2006-2009
Figure 4-2: Egypt - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Middle East and Africa Pharma Sector Forecast to 2012 Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 4-3: Egypt - Share of Generics and Branded Drugs in Pharmaceutical Market (2008)
Figure 4-4: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-5: Egypt - Share of Top Players in Pharmaceutical Market (2008)
Figure 4-6: Nigeria - Pharmaceutical Market (Million US$), 2007-2009
Figure 4-7: Nigeria - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-8: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 4-9: South Africa - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-10: South Africa - Share of Generics and Branded Drugs in Pharmaceutical Market (2008)
Figure 4-11: South Africa - Share of OTC and Prescription Drugs in Pharmaceutical Market (2008)
Figure 4-12: South Africa - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-13: Israel - Pharmaceutical Market (Billion US$), 2006-2009
Figure 4-14: Israel - Share of Generics and Branded Drugs in Pharmaceutical Market (2008)
Figure 4-15: Israel - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-16: Israel - Pharmaceutical Export by Country (%), 2008
Figure 4-17: Israel - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
Figure 4-18: Saudi Arabia - Pharmaceutical Market (Billion SR), 2006-2009
Figure 4-19: Saudi Arabia - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-20: Saudi Arabia - Pharmaceutical Imports by Country (%)
Figure 4-21: Saudi Arabia - Forecast for Pharmaceutical Market (Billion SR), 2010-2012
Figure 4-22: UAE - Pharmaceutical Market (Million US$), 2007-2009
Figure 4-23: UAE - Share of OTC and Prescription Drugs in Pharmaceutical Market (2008)
Figure 4-24: UAE - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-25: UAE - Forecast for Pharmaceutical Market (Million US$), 2010-2012
Figure 4-26: Algeria - Pharmaceutical Market (Billion US$), 2007-2009
Figure 4-27: Algeria - Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-28: Algeria - Share of Generics and Branded Drugs in Pharmaceutical Market (2008)
Figure 4-29: Algeria - Forecast for Pharmaceutical Market (Billion US$), 2010-2012
List of Tables:
Table 2-1: Global - Leading Drug Sales (Billion US$), 2008
Table 4-1: Egypt - Healthcare Statistics (2007-2009)
Table 4-2: Nigeria - Healthcare Statistics (2007-2009)
Table 4-3: South Africa - Healthcare Statistics (2007-2009)
Table 4-4: Israel - Healthcare Statistics (2007-2009)
Table 4-5: Saudi Arabia - Healthcare Statistics (2007-2009)
Table 4-6: Saudi Arabia - Share of Top Ten Players in Pharmaceutical Market by Sales Value
Table 4-7: Algeria - Healthcare Statistics (2007-2009)
Middle East and Africa Pharma Sector Forecast to 2012 Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Middle East and Africa Pharma Sector Forecast to 2012
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 200.00 Quantity: _____
Hard Copy--USD 1 400.00 Quantity: _____
CD-ROM--USD 1 400.00 Quantity: _____
Corporate License--USD 1 800.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Middle East and Africa Pharma Sector Forecast to 2012 Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Middle East and Africa Pharma Sector Forecast to 2012 Page 5/5